Priming effect with G-CSF enhances in vitro apoptosis by treatment with Ara-c and VP-16 in leukemic cell line

被引：0
|
作者：
Kitagawa, Jun-Ichi [1 ]
Hara, Takeshi [1 ]
Tsurumi, Hisashi [1 ]
Kanemura, Nobuhiro [1 ]
Shimizu, Masahito [1 ]
Moriwai, Hisataka [1 ]
机构：
[1] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4333.4333
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4333
引用
下载
收藏
页码：151B / 151B
页数：1
相关论文
共 50 条
  • [1] Ara-C/VP-16 with G-CSF effectively mobilizes CD34+ cells for autologous transplants (PBSCT).
    SarkodeeAdoo, C
    OConnell, B
    Sridhara, R
    Caudill, J
    Lee, E
    CottlerFox, M
    BLOOD, 1997, 90 (10) : 4257 - 4257
  • [2] G-CSF influence on apoptosis induced by ATRA and VP-16 in P39 cell line.
    Syruckova, Z
    Forsblom, A
    HellstromLindberg, E
    BLOOD, 1997, 90 (10) : 3486 - 3486
  • [3] AGGRESSIVE INDUCTION CHEMOTHERAPY WITH IDARUBICIN, ARA-C, VP-16, FOLLOWED BY G-CSF AND MAINTENANCE IMMUNOTHERAPY WITH INTERLEUKIN-2 FOR HIGH-RISK ANLL
    GANSER, A
    HEIL, G
    SEIPELT, G
    FISCHER, JT
    LANGER, G
    BROCKHAUS, W
    ITTEL, TH
    FUHR, HG
    BERGMANN, L
    HOELZER, D
    BLOOD, 1993, 82 (10) : A128 - A128
  • [4] Etoposide (VP-16)+G-CSF mobilizes different dendritic cell subsets than does G-CSF alone.
    Bolwell, BJ
    Sobecks, R
    Pohlman, B
    Andresen, S
    Bell, K
    Bernhard, L
    Koennecke, J
    Serafino, S
    Ostendorf, H
    Theil, K
    Kuczkowski, E
    Rybicki, L
    Jarvis, J
    Kalaycio, M
    BLOOD, 2001, 98 (11) : 180A - 180A
  • [5] Peripheral blood stem cell mobilization using sequential G-CSF alone followed by CTX/VP-16/G-CSF
    Akard, LP
    Dugan, MJ
    Greenspan, A
    Hanks, S
    Thompson, JM
    Wiemann, MC
    Jansen, J
    BLOOD, 1996, 88 (10) : 3655 - 3655
  • [6] Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone
    B Bolwell
    R Sobecks
    B Pohlman
    S Andresen
    K Theil
    S Serafino
    L Rybicki
    M Kalaycio
    Bone Marrow Transplantation, 2003, 31 : 95 - 98
  • [7] Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone
    Bolwell, B
    Sobeeks, R
    Pohlman, B
    Andresen, S
    Theil, K
    Serafino, S
    Rybicki, L
    Kalaycio, M
    BONE MARROW TRANSPLANTATION, 2003, 31 (02) : 95 - 98
  • [8] G-CSF-priming combined with chemotherapy (idarubicin, Ara-C, VP-16) yields high remission rates in patients with advanced myelodysplastic syndromes and high-risk AML.
    Ganser, A
    Hofmann, WK
    Heil, G
    Ottmann, OG
    Fischer, JT
    Langer, W
    Herrmann, WK
    Knuth, A
    Hoffken, K
    Kolbe, K
    Schmoll, HJ
    Hertenstein, B
    Hoelzer, D
    BLOOD, 1996, 88 (10) : 834 - 834
  • [9] Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells
    Bai, A
    Kojima, H
    Hori, M
    Nara, N
    Komeno, T
    Hasegawa, Y
    Ninomiya, H
    Abe, T
    Nagasawa, T
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (02) : 259 - 265
  • [10] Aggressive chemotherapy with idarubicin, Ara-C, VP-16, amsacrin, followed by G-CSF and maintenance immunotherapy with interleukin-2 for advanced myelodysplastic syndromes and high-risk ANLL.
    Ganser, A
    Heil, G
    Hofmann, WK
    Ottmann, OG
    Seipelt, G
    Fischer, JT
    Langer, W
    Brockhaus, W
    Ittel, TH
    Brack, N
    Knuth, A
    Hoffken, K
    Klausmann, M
    Fuhr, HG
    Bergmann, L
    Hoelzer, D
    BLOOD, 1995, 86 (10) : 1722 - 1722
12345